Proactive Investors - Run By Investors For Investors

Cannabics Pharmaceuticals opens up new lab and prepares to accept fresh biopsies

Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO Eyal Barad joined Proactive Investors' Steve Darling at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. The biotechnology company develops pharmaceuticals focusing on cancer research and focuses on the development of therapies and tools aimed at diverse ailments.

 
Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full CNBX profile View Profile

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use